Natalia Belen Pedroza-Aconcha

Ms. Natalia Belen Pedroza-Aconcha

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2024 in Cells
Verified
Journal Article
Open access
PDF file
Beatriz Andrea Otálora-OtáloraBeatriz Andrea Otálora-Otálora
Beatriz Andrea Otálora-Otálora
CPCesar Payan
Cesar Payan
JLJuan Javier Lopez-Rivera
Juan Javier Lopez-Rivera
NPNatalia Belen Pedroza-Aconcha
Natalia Belen Pedroza-Aconcha
SASally Lorena Arboleda-Mojica
Sally Lorena Arboleda-Mojica
CACarlos Alvarez-Moreno
Carlos Alvarez-Moreno
Inflammation can positively and negatively affect tumorigenesis based on the duration, scope, and sequence of related events through the regulation of signaling pathways. A transcriptomic analysis of five pulmonary arterial hypertension, twelve Crohn’s disease, and twelve ulcerative colitis high throughput sequencing datasets using R language specialized libraries and gene enrichment analyses identified a regulatory network in each inflammatory disease. IRF9 and LINC01089 in pulmonary arterial hypertension are related to the regulation of signaling pathways like MAPK, NOTCH, human papillomavirus, and hepatitis c infection. ZNF91 and TP53TG1 in Crohn’s disease are related to the regulation of PPAR, MAPK, and metabolic signaling pathways. ZNF91, VDR, DLEU1, SATB2-AS1, and TP53TG1 in ulcerative colitis are related to the regulation of PPAR, AMPK, and metabolic signaling pathways. The activation of the transcriptomic network and signaling pathways might be related to the interaction of the characteristic microbiota of the inflammatory disease, with the lung and gut cell receptors present in membrane rafts and complexes. The transcriptomic analysis highlights the impact of several coding and non-coding RNAs, suggesting their relationship with the unlocking of cell phenotypic plasticity for the acquisition of the hallmarks of cancer during lung and gut cell adaptation to inflammatory phenotypes.